Japan's health ministry to halt new use of vasculitis drug Tabneos, mulls revoking approval

Japan's health ministry has decided to halt new administration of the vasculitis drug Tabneos, judging that clinical trial problems mean it cannot be used as evidence of efficacy. Current patients will be considered for discontinuation or switching, and administrative procedures including possible revocation of approval are expected within the year.

Detected & updated continuously · Source: Nebula